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Figure 1 Tocopherol polyethylene glycol succinate
(existing molecule)
Figure 2 Polyoxyethylated castor oil (existing molecule)
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The molecules Tocopherol polyethylene glycol
succ inate  (TPGS)  (F igure  1)  and
polyoxyethylated castor oil (Figure 2) are
amphiphiles and are used as solubilizers to
enable aqueous solubility enhancement of
hydrophobic molecules. Could the paradigm of
succinylation followed by polyethoxylation be
applied to food ingredients that present with
inherent properties?
Food ingredients, such as the vanilloid
capsaicin, which is the active constituent of chili
peppers, the curcuminoid phenol, curcumin,
the major constituent of the spice turmeric, and
lignin, laricirecinol, which occurs in flaxseed
and sesame seed, have been documented to
possess antiproliferative and antitumorigenic
properties. Capsaicin acts by blocking the
degradation of IKBα, thereby preventing the
translocation of the p65 subunit of NF-κB to
the nucleus. It has also been reported to inhibit
mitochondrial respiration by altering the
permeability of the inner mitochondrial
membrane. Curcumin acts on a host of
pharmacological targets. It activates caspases
and stimulates the release of cytochrome C,
upregulates the proapoptotic factors BAX and
AIF and downregulates the antiapoptotic
factors Bcl-2 and Bcl-xL. It also inhibits growth
factors such as EGF, VEGF and IGF-1. It has
also been reported to inactivate HIF-1 via
ARNT degradation. Lignans, such as
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Figure 5 Laricirecinol polyethylene glycol succinate
(non-existent, un-synthesized, proposed molecule)
Figure 4 Curcumin polyethylene glycol succinate (non-
existent, un-synthesized, proposed molecule)
Figure 3 Capsaicin polyethylene glycol succinate (non-
existent, un-synthesized, proposed molecule)
laricirecinol, inhibit estrogen induced
angiogenic factors and downregulate VEGF.
Flavonoids such as Quercetin have been
reported to possess anticancer properties,
probably due to the scavenging of reactive
oxygen species (ROS).
The hydroxyl methoxy benzyl moiety present in
the above food ingredients occurs as a
recurrent motif in the structure of
antitumorigenic compounds. This structure is
an agonist for the vanilloid receptor which has
recently been implicated in the modulation of
apoptosis in actively proliferating cancer cells.
It is therefore advantageous to succinylate (and
subsequent ly  polyoxyethylate)  these
compounds at a structural location other than
the hydroxyl methoxy benzyl motifs (Figures 3,
4 and 5) so as to maximize the probability of
retaining their antitumor activity. It appears that
such a modification, i.e., monoesterification at
selected hydroxyls is possible as has been
demonstrated by the enzymatic regioselective
monoesterification of flavonoids such as
naringin and flavonin. The ketone group in
capsaicin (Figure 3) is assumed to be capable of
reduction to a hydroxyl before subsequent
esterification and polyethoxylation. In
summary, synthesizing the structures presented
in Figures 3-5 does not seem to be an
unsurmountable proposition.
Converting these hydrophobic food ingredients
into amphiphilic compounds creates an
opportunity whereby these amphiphiles can be
used as ‘excipient solubilizers’ for increasing the
solubility of APIs with a prominent mechanism
of action (such as tyrosine kinase inhibitors),
whilst themselves retaining their anticancer
properties.
This approach is advantageous for several
reasons. Extensive toxicological studies need
not be performed on these ‘excipients’ because
they are not professed to be active
pharmaceutical ingredient(s) in the formulation.
The regulatory burden is consequently
decreased significantly. Assuming that these
excipient molecules retain their ‘pre-
amphiphilic’ anticancer properties to a
significant extent, the probability of such
formulations meeting clinical survival endpoints
becomes logically more likely when compared
to ‘current best in class’ API formulations.
They can be formulated with hydrophobic APIs
regardless of the API mechanism(s) of action
because these excipient solubilizers, for the
most part, act on multiple pharmacological
cancer signaling pathways making them
‘generic’ in effect, regardless of the tumor
genesis, type or location in the body. In fact,
the solubilizers can be chosen so that their
mechanism(s) of action complement those of
the API, thereby theoretically improving the
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clinical efficacy.
It may turn out that these solubilizers acquire
additional antitumor mechanisms, or biological
modifier mechanisms of action, that originate
by dint of their amphiphilic nature. By all
accounts, polyoxyetylated castor oil was not
specifically selected as a solubilizer because it
possessed efflux pump inhibitor activity. This
activity was discovered later and fortuitously
found to enhance the effect of the API. On the
other hand, excipient molecule solubilizers that
I suggest be synthesized/created, are already
known to be potent antitumor agents in their
‘non-amphiphilic’ state. If, by virtue of their
acquiring amphiphilic properties, they turn out
to be MDR inhibitors as well, so much the
better.
The paradigm of converting food ingredients
with biological activity into excipients by
‘amphiphilization’ may even be extended to
converting APIs into excipient solubilizers. As
an example, there appears no a priori reason
why the podophyllotoxin skeleton, the starting
lead for a number of extremely efficacious
cytotoxic agents such as etoposide and
teniposide cannot be esterified and
polyoxyethylated so to allow the resultant
molecules to function as amphiphilic
solubilizing excipients.
Scientists have retrospectively discovered that
currently used excipient solubilizers such as
TPGS and polyoxyethylated castor oil
derivatives possess biological activity that
enhances the API effect. Why not take a more
proactive approach and deliberately design such
excipient molecules and/or solubilizers?
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